Breast Cancer Resources

home  »  cancer resources »  breast cancer

Breast Cancer Treatment Research and Sources of Information & Support

Kenneth S. Pope, Ph.D., ABPP

The resources on this page are intended to help people with breast cancer and their loved ones to find information, support, and other resources. These resources are meant to complement and not replace any advice or information from a health care professional.

This site is designed to be fully accessible for people with disabilities; please follow this link to change text size, color, or contrast; please follow this link for other accessibility functions for those with visual, mobility, and other disabilities.

There are 4 sections of resources:

1) Books

2) Recent research articles on breast cancer treatments

3) Recent article on psychological aspects of breast cancer

4) Links to web sites providing information and support

PLEASE NOTE: This web site includes 6 other pages of related sets of resources:

BOOKS:

RECENT (I.E., PUBLISED IN 2009, 2010, 2011), or 2012) RESEARCH ARTICLES ON TREATMENT APPROACHES FOR BREAST CANCER

  1. Aapro, M., Monfardini, S., Jirillo, A., & Basso, U. (2009). Management of primary and advanced breast cancer in older unfit patients (medical treatment). [Review]. Cancer treatment reviews, 35(6), 503-508.
  2. Abdulkareem, I. H., & Zurmi, I. B. (2012). Review of hormonal treatment of breast cancer. Niger J Clin Pract, 15(1), 9-14. doi: 10.4103/1119-3077.94088
  3. Agrawal, K., Onami, S., Mortimer, J. E., & Pal, S. K. (2010). Cognitive changes associated with endocrine therapy for breast cancer. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Maturitas, 67(3), 209-214.
  4. Al-Tweigeri, T. A., Ajarim, D. S., Alsayed, A. A., Rahal, M. M., Alshabanah, M. O., Tulbah, A. M., et al. (2010). Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer. [Clinical Trial, Phase II Research Support, Non-U.S. Gov't]. Medical oncology, 27(3), 571-577.
  5. Alkner, S., Bendahl, P. O., Ferno, M., Nordenskjold, B., & Ryden, L. (2009). Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial. [Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't]. European journal of cancer, 45(14), 2496-2502.
  6. Aristei, C., Leonardi, C., Stracci, F., Palumbo, I., Luini, A., Viale, G., et al. (2011). Risk factors for relapse after conservative treatment in T1-T2 breast cancer with one to three positive axillary nodes: results of an observational study. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 22(4), 842-847.
  7. Ameen, S., Qadir, M. I., & Ahmad, B. (2012). Review: Pharmacogenomic approaches in the treatment of breast cancer by tamoxifen. Pak J Pharm Sci, 25(2), 469-476.
  8. Amiri-Kordestani, L., Tan, A. R., & Swain, S. M. (2012). Pazopanib for the treatment of breast cancer. [Research Support, N.I.H., Extramural Review]. Expert Opin Investig Drugs, 21(2), 217-225. doi: 10.1517/13543784.2012.652304
  9. Aristei, C., Palumbo, I., Cucciarelli, F., Cavalli, A., Tarducci, R., Raymondi, C., et al. (2009). Partial breast irradiation with interstitial high-dose-rate brachytherapy in early breast cancer: results of a phase II prospective study. [Clinical Trial, Phase II Comparative Study Randomized Controlled Trial]. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 35(2), 144-150.
  10. Azim, H. A., Jr., Peccatori, F. A., Liptrott, S. J., Catania, C., & Goldhirsch, A. (2009). Breast cancer and pregnancy: how safe is trastuzumab? [Case Reports Research Support, Non-U.S. Gov't]. Nature reviews. Clinical oncology, 6(6), 367-370.
  11. Bergh, J., Bondarenko, I. M., Lichinitser, M. R., Liljegren, A., Greil, R., Voytko, N. L., et al. (2012). First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study. [Research Support, Non-U.S. Gov't]. J Clin Oncol, 30(9), 921-929.
  12. Biglia, N., Moggio, G., Peano, E., Sgandurra, P., Ponzone, R., Nappi, R. E., et al. (2010). Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight. The journal of sexual medicine, 7(5), 1891-1900.
  13. Binkley, J. M., Harris, S. R., Levangie, P. K., Pearl, M., Guglielmino, J., Kraus, V., et al. (2012). Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer. Cancer, 118(8 Suppl), 2207-2216.
  14. Boer, K., Lang, I., Llombart-Cussac, A., Andreasson, I., Vivanco, G. L., Sanders, N., et al. (2012). Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study. [Research Support, Non-U.S. Gov't]. Invest New Drugs, 30(2), 681-687.
  15. Boonstra, A., van Zadelhoff, J., Timmer-Bonte, A., Ottevanger, P. B., Beurskens, C. H., & van Laarhoven, H. W. (2012). Arthralgia During Aromatase Inhibitor Treatment in Early Breast Cancer Patients: Prevalence, Impact, and Recognition by Healthcare Providers. Cancer Nurs. doi: 10.1097/NCC.0b013e31824a7e18
  16. Bramwell, V. H., Pritchard, K. I., Tu, D., Tonkin, K., Vachhrajani, H., Vandenberg, T. A., et al. (2010). A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada--Clinical Trials Group Trial, MA.12). [Randomized Controlled Trial Research Support, Non-U.S. Gov't]. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 21(2), 283-290.
  17. Brown, S., & Khan, D. R. (2012). The treatment of breast cancer using liposome technology. J Drug Deliv, 2012, 212965. doi: 10.1155/2012/212965
  18. Carlson, R. W., O'Neill, A., Vidaurre, T., Gomez, H. L., Badve, S. S., & Sledge, G. W. (2012). A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer. Breast Cancer Res Treat. doi: 10.1007/s10549-012-1997-5
  19. Chen, W. C., Kim, J., Kim, E., Silverman, P., Overmoyer, B., Cooper, B. W., et al. (2012). A phase II study of radiotherapy and concurrent paclitaxel chemotherapy in breast-conserving treatment for node-positive breast cancer. [Clinical Trial, Phase II]. Int J Radiat Oncol Biol Phys, 82(1), 14-20.
  20. Chia, Y. H., Ellis, M. J., & Ma, C. X. (2010). Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review]. British journal of cancer, 103(6), 759-764.
  21. Christensen, M. H., & Petersen, L. J. (2012). Radionuclide treatment of painful bone metastases in patients with breast cancer: a systematic review. Cancer Treat Rev, 38(2), 164-171. doi: 10.1016/j.ctrv.2011.05.008
  22. Coleman, R. E., Bertelli, G., Beaumont, T., Kunkler, I., Miles, D., Simmonds, P. D., et al. (2012). UK guidance document: treatment of metastatic breast cancer. [Research Support, Non-U.S. Gov't]. Clin Oncol (R Coll Radiol), 24(3), 169-176. doi: 10.1016/j.clon.2011.10.004
  23. Colleoni, M., Bagnardi, V., Rotmensz, N., Viale, G., Mastropasqua, M., Veronesi, P., et al. (2010). A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer. [Research Support, Non-U.S. Gov't Validation Studies]. European journal of cancer, 46(12), 2216-2224.
  24. Colleoni, M., Sun, Z., Martinelli, G., Basser, R. L., Coates, A. S., Gelber, R. D., et al. (2009). The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up. [Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 20(8), 1344-1351.
  25. Collins, B., Mackenzie, J., Stewart, A., Bielajew, C., & Verma, S. (2009). Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psycho-oncology, 18(2), 134-143.
  26. Collins, B., Mackenzie, J., Stewart, A., Bielajew, C., & Verma, S. (2009). Cognitive effects of hormonal therapy in early stage breast cancer patients: A prospective study. Psycho-oncology, 18(8), 811-821.
  27. Costa, S. D., Loibl, S., Kaufmann, M., Zahm, D. M., Hilfrich, J., Huober, J., et al. (2010). Neoadjuvant chemotherapy shows similar response in patients with inflammatory or locally advanced breast cancer when compared with operable breast cancer: a secondary analysis of the GeparTrio trial data. [Comparative Study Randomized Controlled Trial Research Support, Non-U.S. Gov't]. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28(1), 83-91.
  28. Darb-Esfahani, S., Loibl, S., Muller, B. M., Roller, M., Denkert, C., Komor, M., et al. (2009). Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy. [Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't]. Breast cancer research : BCR, 11(5), R69.
  29. Delozier, T. (2010). [Hormonal treatment in breast cancer]. [Review]. Journal de gynecologie, obstetrique et biologie de la reproduction, 39(8 Suppl), F71-78.
  30. Dooley, W. C., Bong, J., & Parker, J. (2011). Mechanisms of Improved Outcomes for Breast Cancer between Surgical Oncologists and General Surgeons. Annals of surgical oncology.
  31. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). (2011, October 20). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet, online in advance of publication; no pagination.
  32. Eremin, O., Walker, M. B., Simpson, E., Heys, S. D., Ah-See, A. K., Hutcheon, A. W., et al. (2009). Immuno-modulatory effects of relaxation training and guided imagery in women with locally advanced breast cancer undergoing multimodality therapy: a randomised controlled trial. [Randomized Controlled Tria Research Support, Non-U.S. Gov't]. Breast, 18(1), 17-25.
  33. Filipits, M., Rudas, M., Heinzl, H., Jakesz, R., Kubista, E., Lax, S., et al. (2009). Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy. Clinical cancer research : an official journal of the American Association for Cancer Research, 15(18), 5888-5894.
  34. Fornier, M., & Fumoleau, P. (2012). The paradox of triple negative breast cancer: novel approaches to treatment. [Research Support, Non-U.S. Gov't]. Breast J, 18(1), 41-51. doi: 10.1111/j.1524-4741.2011.01175.x
  35. Freedman, G. M. (2012). Hypofractionated radiation therapy in the treatment of early-stage breast cancer. [Review]. Curr Oncol Rep, 14(1), 12-19. doi: 10.1007/s11912-011-0207-7
  36. Fujisawa, M., Uomori, T., Takehara, K., Mitsugi, Y., Yoshino, K., Okumura, M., et al. (2009). [A case of recurrent breast cancer responding to vinorelbine/trastuzumab combination therapy]. [Case Reports]. Gan to kagaku ryoho. Cancer & chemotherapy, 36(13), 2631-2635.
  37. Gandhi, S., & Verma, S. (2011). Early breast cancer in the older woman. The oncologist, 16(4), 479-485.
  38. Ganz, P. A., Land, S. R., Geyer, C. E., Jr., Cecchini, R. S., Costantino, J. P., Pajon, E. R., et al. (2011). Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial. [Randomized Controlled Trial]. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29(9), 1110-1116.
  39. Garcia-Estevez, L., Tusquets, I., Alvarez, I., Rodriguez, C., Fernandez, Y., Segui, M. A., et al. (2010). Supportive care for patients with early breast cancer. [Research Support, Non-U.S. Gov't Review]. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 12(1), 32-42.
  40. Gerber, B., Freund, M., & Reimer, T. (2010). Recurrent breast cancer: treatment strategies for maintaining and prolonging good quality of life. [Review]. Deutsches Arzteblatt international, 107(6), 85-91.
  41. Gluz, O., Mengele, K., Schmitt, M., Kates, R., Diallo-Danebrock, R., Neff, F., et al. (2009). Y-box-binding protein YB-1 identifies high-risk patients with primary breast cancer benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy. [Clinical Trial, Phase III Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't]. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27(36), 6144-6151.
  42. Gnant, M. (2012). Zoledronic acid in the treatment of early-stage breast cancer: is there a final verdict? [Review]. Curr Oncol Rep, 14(1), 35-43. doi: 10.1007/s11912-011-0209-5
  43. Goel, S., Sharma, R., Hamilton, A., & Beith, J. (2009). LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women. [Meta-Analysis Review]. Cochrane database of systematic reviews(4), CD004562.
  44. Goldman, M., & O'Hair, K. (2009). Women's health, breast health: a review of the gynecologic effects of breast cancer. [Review]. Obstetrical & gynecological survey, 64(7), 469-480; quiz 499.
  45. Gonzalez, M. R., Marcelo, C. D., & Stringer, M. (2009). Hospice care for 86 year old male with recurrent breast cancer: a case report. Cases journal, 2, 8357.
  46. Goyal, S., Puri, T., Gupta, R., Suri, V., Julka, P. K., & Rath, G. K. (2010). Tibial involvement in breast cancer: issues in diagnosis and management. [Case Reports]. Foot, 20(1), 35-38.
  47. Grant, C. S., Ingle, J. N., Suman, V. J., Dumesic, D. A., Wickerham, D. L., Gelber, R. D., et al. (2009). Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study. [Clinical Trial, Phase III Comparative Study Research Support, N.I.H., Extramural]. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27(22), 3620-3626.
  48. Greil, R., Moik, M., Reitsamer, R., Ressler, S., Stoll, M., Namberger, K., et al. (2009). Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot study. [Clinical Trial, Phase II Research Support, Non-U.S. Gov't]. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 35(10), 1048-1054.
  49. Griffths, C. L., & Olin, J. L. (2012). Triple Negative Breast Cancer: A Brief Review of its Characteristics and Treatment Options. J Pharm Pract. doi: 10.1177/0897190012442062
  50. Guarneri, V., Barbieri, E., Piacentini, F., Giovannelli, S., Ficarra, G., Frassoldati, A., et al. (2010). Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis. [Evaluation Studies Research Support, Non-U.S. Gov't]. The International journal of biological markers, 25(2), 104-111.
  51. Hackshaw, A., Baum, M., Fornander, T., Nordenskjold, B., Nicolucci, A., Monson, K., et al. (2009). Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer. [Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't]. Journal of the National Cancer Institute, 101(5), 341-349.
  52. Hamaker, M. E., Schreurs, W. H., van Slooten, H. J., Uppelschoten, J. M., & Smorenburg, C. H. (2009). [Trends in breast cancer treatment in the elderly at a breast cancer outpatient clinic: guidelines followed better]. Nederlands tijdschrift voor geneeskunde, 153, A562.
  53. Hatzis, C., Pusztai, L., Valero, V., Booser, D. J., Esserman, L., Lluch, A., et al. (2011). A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA: Journal of the American Medical Association, 305(18), 1873-1881.
  54. Hirano, A., Shimizu, T., Kamimura, M., Ogura, K., Kim, N., Setoguchi, Y., et al. (2011). [Responses to primary systemic therapy for breast cancer as assessed by hormone receptor and HER2 status]. Gan to kagaku ryoho. Cancer & chemotherapy, 38(5), 771-776.
  55. Howard, J. H., & Bland, K. I. (2012). Current management and treatment strategies for breast cancer. [Review]. Curr Opin Obstet Gynecol, 24(1), 44-48. doi: 10.1097/GCO.0b013e32834da4b1
  56. Huang, O., Chen, C., Wu, J., Chen, S., Chen, X., Liu, G., et al. (2009). Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 months. BMC cancer, 9, 375.
  57. Huang, O., Chen, C. M., Wu, J. Y., Hu, Z., Hou, Y. F., Zhang, J. X., et al. (2009). [Study on predictors of long term results for neo-adjuvant chemotherapy in locally advanced breast cancer]. Zhonghua wai ke za zhi [Chinese journal of surgery], 47(7), 511-515.
  58. Hubalek, M., Brantner, C., & Marth, C. (2010). Adjuvant endocrine therapy of premenopausal women with early breast cancer: an overview. Wiener medizinische Wochenschrift, 160(7-8), 167-173.
  59. Huober, J., von Minckwitz, G., Denkert, C., Tesch, H., Weiss, E., Zahm, D. M., et al. (2010). Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study. [Clinical Trial, Phase III Multicenter Study Randomized Controlled Trial]. Breast cancer research and treatment, 124(1), 133-140.
  60. Inoue, H., Yano, H., Shimabukuro, R., Shiraishi, T., Takahashi, I., Nishizaki, T., et al. (2010). [A case of capecitabine-resistant recurrent breast cancer found to be responsive to S-1]. [Case Reports]. Gan to kagaku ryoho. Cancer & chemotherapy, 37(13), 2909-2911.
  61. Ionta, M. T., Atzori, F., Deidda, M. C., Pusceddu, V., Palmeri, S., Frau, B., et al. (2009). Long-term outcomes in stage IIIB breast cancer patients who achieved less than a pathological complete response (<pCR) after primary chemotherapy. The oncologist, 14(11), 1051-1060.
  62. Ishitobi, M., Komoike, Y., Motomura, K., Koyama, H., Nishiyama, K., & Inaji, H. (2009). Retrospective analysis of concurrent vs. sequential administration of radiotherapy and hormone therapy using aromatase inhibitor for hormone receptor-positive postmenopausal breast cancer. Anticancer research, 29(11), 4791-4794.
  63. Iwata, H. (2011). Neoadjuvant endocrine therapy for postmenopausal patients with hormone receptor-positive early breast cancer: a new concept. [Research Support, Non-U.S. Gov't]. Breast cancer, 18(2), 92-97.
  64. Jack, R. H., Davies, E. A., & Moller, H. (2009). Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England. British journal of cancer, 100(3), 545-550.
  65. Jung, M., Shin, H. J., Rha, S. Y., Jeung, H. C., Hong, S., Moon, Y. W., et al. (2010). The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up. [Comparative Study Research Support, Non-U.S. Gov't]. Annals of surgical oncology, 17(12), 3259-3268.
  66. Keating, G. M. (2012). Pertuzumab: in the first-line treatment of HER2-positive metastatic breast cancer. [Review]. Drugs, 72(3), 353-360. doi: 10.2165/11209000-000000000-00000
  67. Knauer, M., Gnant, M., & Fitzal, F. (2012). Results of the First Austrian Multidisciplinary Expert Panel on Controversies in Local Treatment of Breast Cancer. Breast Care (Basel), 7(1), 61-66. doi: 10.1159/000336983
  68. Konishi, K., Hasegawa, N., Kaneko, H., Iimura, Y., Shoji, Y., & Kawabata, M. (2010). [A case of premenopausal stage IV breast cancer responding to neoadjuvant endocrine therapy after chemotherapy with FEC]. [Case Reports]. Gan to kagaku ryoho. Cancer & chemotherapy, 37(1), 111-113.
  69. Krychman, M. L., & Katz, A. (2012). Breast cancer and sexuality: multi-modal treatment options. J Sex Med, 9(1), 5-13; quiz 14-15. doi: 10.1111/j.1743-6109.2011.02566.x
  70. Laki, F., Kirova, Y. M., Savignoni, A., Campana, F., Levu, B., Esteve, M., et al. (2010). Management of operable invasive breast cancer in women over the age of 70: long-term results of a large-scale single-institution experience. [Comparative Study]. Annals of surgical oncology, 17(6), 1530-1538.
  71. Lawrenz, B., Neunhoeffer, E., Henes, M., Lessmann-Bechle, S., Kramer, B., & Fehm, T. (2010). Management of fertility preservation in young breast cancer patients in a large breast cancer centre. Archives of gynecology and obstetrics, 282(5), 547-551.
  72. Lemieux, J., Goodwin, P. J., Bordeleau, L. J., Lauzier, S., & Theberge, V. (2011). Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001-2009). [Research Support, Non-U.S. Gov't Review]. Journal of the National Cancer Institute, 103(3), 178-231.
  73. Liao, N., Zhang, G. C., Li, X. R., Yao, M., Wang, K., & Zu, J. (2010). [Efficacy and safety assessment of neoadjuvant paclitaxel and trastuzumab in Chinese women with Her-2 positive operable breast cancer]. [Clinical Trial, Phase II Research Support, Non-U.S. Gov't]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 32(7), 544-547.
  74. Love, R. R. (2010). Adjuvant hormonal therapy in premenopausal women with operable breast cancer: not-so-peripheral perspectives. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review]. Oncology, 24(4), 322-327.
  75. Ma, C. X., Sanchez, C. G., & Ellis, M. J. (2009). Predicting endocrine therapy responsiveness in breast cancer. [Review]. Oncology, 23(2), 133-142.
  76. Mamounas, E. P., Tang, G., Fisher, B., Paik, S., Shak, S., Costantino, J. P., et al. (2010). Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28(10), 1677-1683.
  77. Manga, G. P., Shahi, P. K., Urena, M. M., Pereira, R. Q., Plaza, M. I., Peron, Y. I., et al. (2010). Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer. [Clinical Trial, Phase II Multicenter Study]. Breast cancer, 17(3), 205-211.
  78. Martin, M., Segui, M. A., Anton, A., Ruiz, A., Ramos, M., Adrover, E., et al. (2010). Adjuvant docetaxel for high-risk, node-negative breast cancer. [Clinical Trial, Phase III Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't]. The New England journal of medicine, 363(23), 2200-2210.
  79. Maughan, K. L., Lutterbie, M. A., & Ham, P. S. (2010). Treatment of breast cancer. [Review]. American family physician, 81(11), 1339-1346.
  80. Montgomery, G. H., Kangas, M., David, D., Hallquist, M. N., Green, S., Bovbjerg, D. H., et al. (2009). Fatigue during breast cancer radiotherapy: An initial randomized study of cognitive–behavioral therapy plus hypnosis. Health Psychology, 28(3), 317-322.
  81. Morcos, B., Jaradat, I., & El-Ghanem, M. (2011). Characteristics of and therapeutic options for contralateral axillary lymph node metastasis in breast cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 37(5), 418-421.
  82. Morrow, P. K., Murthy, R. K., Ensor, J. D., Gordon, G. S., Margolin, K. A., Elias, A. D., et al. (2012). An open-label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer. Cancer. doi: 10.1002/cncr.26730
  83. Muss, H. B., Berry, D. A., Cirrincione, C. T., Theodoulou, M., Mauer, A. M., Kornblith, A. B., et al. (2009). Adjuvant chemotherapy in older women with early-stage breast cancer. [Comparative Study Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. The New England journal of medicine, 360(20), 2055-2065.
  84. Napieralski, R., Brunner, N., Mengele, K., & Schmitt, M. (2010). Emerging biomarkers in breast cancer care. [Review]. Biomarkers in medicine, 4(4), 505-522.
  85. Ochoa, R., Sudhindra, A., Garcia, M., Romilly, A. P., Cortes, J., Gomez, H., et al. (2012). Small-Cell Cancer of the Breast: What Is the Optimal Treatment? A Report and Review of Outcomes. Clin Breast Cancer. doi: 10.1016/j.clbc.2012.03.007
  86. Okubo, A., Hino, N., Ikushima, Y., Mori, R., Amano, S., Tsuyuguchi, M., et al. (2010). [Two elderly patients with advanced breast cancer successfully treated by tri-weekly docetaxel]. [Case Reports]. Gan to kagaku ryoho. Cancer & chemotherapy, 37(5), 911-914.
  87. O'Shaughnessy, J. A. (2012). Breast cancer in focus: treatment options for triple-negative metastatic breast cancer. Clin Adv Hematol Oncol, 10(1), 43-45.
  88. Olson, J. A., Jr., Budd, G. T., Carey, L. A., Harris, L. A., Esserman, L. J., Fleming, G. F., et al. (2009). Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial. [Clinical Trial, Phase III Multicenter Study Research Support, N.I.H., Extramural]. Journal of the American College of Surgeons, 208(5), 906-914; discussion 915-906.
  89. Ottini, L., Palli, D., Rizzo, S., Federico, M., Bazan, V., & Russo, A. (2010). Male breast cancer. [Review]. Critical reviews in oncology/hematology, 73(2), 141-155.
  90. Park, H. J., Koo, Y. A., Im, Y. H., Yoon, B. K., & Choi, D. (2010). GnRH agonist therapy to protect ovarian function in young Korean breast cancer patients. [Controlled Clinical Trial]. Journal of Korean medical science, 25(1), 110-116.
  91. Partridge, A. H., Archer, L., Kornblith, A. B., Gralow, J., Grenier, D., Perez, E., et al. (2010). Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. [Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural]. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28(14), 2418-2422.
  92. Pezzin, L. E., O'Niel, M. B., & Nattinger, A. B. (2009). The economic consequences of breast cancer adjuvant hormonal treatments. [Comparative Study Research Support, N.I.H., Extramural]. Journal of general internal medicine, 24 Suppl 2, S446-450.
  93. Ravi, A., Bang, H., Karsif, K., & Nori, D. (2012). Breast cancer in men: prognostic factors, treatment patterns, and outcome. Am J Mens Health, 6(1), 51-58. doi: 10.1177/1557988311416495
  94. Rozenowicz Rde, L., Santos, R. E., Silva, M. A., Rodrigues, F. F., Oliveira, A. L., Ulson, L. B., et al. (2010). Cox-2 and its association with prognostic factors and response to primary chemotherapy in patients with breast cancer. Revista do Colegio Brasileiro de Cirurgioes, 37(5), 323-327.
  95. Rugo, H. S., Kohles, J., & Schulman, K. L. (2010). Cost comparison of capecitabine in patients with breast cancer. [Comparative Study Research Support, Non-U.S. Gov't]. American journal of clinical oncology, 33(6), 550-556.
  96. Sakurai, K., Enomoto, K., & Amano, S. (2011). Recovery of menstruation after long-term chemotherapy and endocrine therapy in pre-menopausal patients with breast cancer. Journal of cancer research and clinical oncology, 137(4), 615-620.
  97. Sakurai, K., Matsuo, S., Enomoto, K., Amano, S., & Shiono, M. (2011). Menstruation recovery after chemotherapy and luteinizing hormone-releasing hormone agonist plus tamoxifen therapy for premenopausal patients with breast cancer. Surgery today, 41(1), 48-53.
  98. Sakurai, T., Umemura, T., Jinta, E., Suzuma, T., Yoshimura, G., & Shimizu, S. (2009). [Nineteen years postoperatively, anastrozole, UFT and cyclophosphamide combination therapy remained effective against recurrent hormone responsive breast cancer with intraabdominal lymphnode, pleural, skin and bone metastases in old age following sixteen-year tamoxifen treatment - a case report]. [Case Reports]. Gan to kagaku ryoho. Cancer & chemotherapy, 36(5), 819-821.
  99. Samarasekera, S., & Rajabally, Y. A. (2011). Demyelinating neuropathy with anti-CRMP5 antibodies predating diagnosis of breast carcinoma: favorable outcome after cancer therapy. [Case Reports]. Muscle & nerve, 43(5), 764-766.
  100. Sanchez-Munoz, A., Perez-Ruiz, E., Jurado, J. M., Ribelles, N., Marquez, A., Miramon, J., et al. (2011). Outcome of small invasive breast cancer with no axillary lymph node involvement. The breast journal, 17(1), 32-38.
  101. Sanchez-Munoz, A., Ribelles, N., & Alba, E. (2010). Optimal adjuvant hormonal therapy in postmenopausal women with hormone-receptor-positive early breast cancer: have we answered the question? [Research Support, Non-U.S. Gov't Review]. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 12(9), 614-620.
  102. Sato, T., Nakagawa, T., Kuwayama, T., Kubota, K., Suzuki, S., & Sugihara, K. (2009). [A case of inflammatory breast cancer responding to anastrozole]. [Case Reports]. Gan to kagaku ryoho. Cancer & chemotherapy, 36(12), 2477-2479.
  103. Schneeweiss, A., Marme, F., Ruiz, A., Manikhas, A. G., Bottini, A., Wolf, M., et al. (2011). A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer. [Clinical Trial, Phase II Comparative Study Multicenter Stud Randomized Controlled Trial Research Support, Non-U.S. Gov't]. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 22(3), 609-617.
  104. Schonberg, M. A., Marcantonio, E. R., Li, D., Silliman, R. A., Ngo, L., & McCarthy, E. P. (2010). Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28(12), 2038-2045.
  105. Schwentner, L., Wolters, R., Koretz, K., Wischnewsky, M. B., Kreienberg, R., Rottscholl, R., et al. (2012). Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival-a retrospective multi-centre cohort study. Breast Cancer Res Treat, 132(3), 1073-1080. doi: 10.1007/s10549-011-1935-y
  106. Seo, J. H., Kim, Y. H., & Kim, J. S. (2009). Meta-analysis of pre-operative aromatase inhibitor versus tamoxifen in postmenopausal woman with hormone receptor-positive breast cancer. [Meta-Analysis Research Support, Non-U.S. Gov't]. Cancer chemotherapy and pharmacology, 63(2), 261-266.
  107. Shi, H. Y., Uen, Y. H., Yen, L. C., Culbertson, R., Juan, C. H., & Hou, M. F. (2011). Two-year quality of life after breast cancer surgery: A comparison of three surgical procedures. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 37(8), 695-702.
  108. Short, L. J., Fisher, M. D., Wahl, P. M., Kelly, M. B., Lawless, G. D., White, S., et al. (2010). Disparities in medical care among commercially insured patients with newly diagnosed breast cancer: opportunities for intervention. [Research Support, Non-U.S. Gov't]. Cancer, 116(1), 193-202.
  109. Shumway, N. M., Ibrahim, N., Ponniah, S., Peoples, G. E., & Murray, J. L. (2009). Therapeutic breast cancer vaccines: a new strategy for early-stage disease. [Review]. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 23(5), 277-287.
  110. Singh, Y. P., & Sayami, P. (2009). Management of breast cancer in Nepal. [Review]. JNMA; journal of the Nepal Medical Association, 48(175), 252-257.
  111. Smith, G. L., Xu, Y., Buchholz, T. A., Giordano, S. H., Jiang, J., Shih, Y. C., et al. (2012). Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer. JAMA, 307(17), 1827-1837. doi: 10.1001/jama.2012.3481
  112. Spielmann, M., Roche, H., Delozier, T., Canon, J. L., Romieu, G., Bourgeois, H., et al. (2009). Trastuzumab for patients with axillary-node-positive breast cancer: results of the FNCLCC-PACS 04 trial. [Multicenter Study Randomized Controlled Trial]. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27(36), 6129-6134.
  113. Straver, M. E., Loo, C. E., Rutgers, E. J., Oldenburg, H. S., Wesseling, J., Vrancken Peeters, M. J., et al. (2010). MRI-model to guide the surgical treatment in breast cancer patients after neoadjuvant chemotherapy. Annals of surgery, 251(4), 701-707.
  114. Straver, M. E., Rutgers, E. J., Rodenhuis, S., Linn, S. C., Loo, C. E., Wesseling, J., et al. (2010). The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy. Annals of surgical oncology, 17(9), 2411-2418.
  115. Tahmasebi, S., Akrami, M., Omidvari, S., Salehi, A., & Talei, A. (2010). Male breast cancer; analysis of 58 cases in Shiraz, South of Iran. Breast disease, 31(1), 29-32.
  116. Tamada, S., Sagara, Y., Baba, S., Yotsumoto, D., Matsukata, A., Andou, M., et al. (2011). [A patient with of metastatic breast cancer with a well-controlled quality of life using S-1 therapy as first-line chemotherapy]. [Case Reports]. Gan to kagaku ryoho. Cancer & chemotherapy, 38(4), 635-637.
  117. Toi, M., Sasano, H., & Ellis, M. J. (2009). [Future prospects of neoadjuvant endocrine therapy in postmenopausal breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 36(6), 1035-1042.
  118. Tokugawa, T., Kobayashi, A., Matsuyama, T., Imai, S., & Koyama, H. (2009). [A patient with axillary node metastasis from breast cancer who responded to trastuzumab/capecitabine combination therapy]. [Case Reports]. Gan to kagaku ryoho. Cancer & chemotherapy, 36(3), 467-469.
  119. Tokugawa, T., Kobayashi, A., Okubo, K., Matsuyama, T., Imai, S., & Koyama, H. (2009). [A patient with multiple skin metastases from breast cancer responding to S-1 effectively under treatment with trastuzumab]. [Case Reports]. Gan to kagaku ryoho. Cancer & chemotherapy, 36(4), 679-682.
  120. Tsoutsou, P. G., Belkacemi, Y., Gligorov, J., Kuten, A., Boussen, H., Bese, N., et al. (2010). Optimal sequence of implied modalities in the adjuvant setting of breast cancer treatment: an update on issues to consider. The oncologist, 15(11), 1169-1178.
  121. Tuttle, T. M., Rueth, N. M., Abbott, A., & Virnig, B. A. (2012). United States Trends in the Surgical Treatment of Primary Breast Cancer. World J Surg. doi: 10.1007/s00268-012-1469-4
  122. van der Pol, C. C., van Geel, A. N., Menke-Pluymers, M. B., Schmitz, P. I., & Lans, T. E. (2009). Prognostic factors in 77 curative chest wall resections for isolated breast cancer recurrence. [Clinical Trial]. Annals of surgical oncology, 16(12), 3414-3421.
  123. van Nes, J. G., Seynaeve, C., Maartense, E., Roumen, R. M., de Jong, R. S., Beex, L. V., et al. (2010). Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial. [Clinical Trial, Phase III Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't]. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 21(5), 974-982.
  124. Varga, D., Wischnewsky, M., Atassi, Z., Wolters, R., Geyer, V., Strunz, K., et al. (2010). Does guideline-adherent therapy improve the outcome for early-onset breast cancer patients? Oncology, 78(3-4), 189-195.
  125. von Minckwitz, G., Rezai, M., Loibl, S., Fasching, P. A., Huober, J., Tesch, H., et al. (2010). Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study. [Clinical Trial, Phase III Comparative Study Multicenter Study Randomized Controlled Trial]. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28(12), 2015-2023.
  126. Watanabe, N., Ootawa, Y., Kodama, K., Kaide, A., Ootsuka, N., & Matsuoka, J. (2010). Concurrent administration of chemo-endocrine therapy for postmenopausal breast cancer patients. Breast cancer, 17(4), 247-253.
  127. Wink, C. J., Woensdregt, K., Nieuwenhuijzen, G. A., van der Sangen, M. J., Hutschemaekers, S., Roukema, J. A., et al. (2012). Hormone treatment without surgery for patients aged 75 years or older with operable breast cancer. Ann Surg Oncol, 19(4), 1185-1191. doi: 10.1245/s10434-011-2070-z
  128. Wolters, R., Regierer, A. C., Schwentner, L., Geyer, V., Possinger, K., Kreienberg, R., et al. (2012). A comparison of international breast cancer guidelines - do the national guidelines differ in treatment recommendations? [Comparative Study]. Eur J Cancer, 48(1), 1-11. doi: 10.1016/j.ejca.2011.06.020
  129. Yavari, P., Barroetavena, M. C., Hislop, T. G., & Bajdik, C. D. (2010). Breast cancer treatment and ethnicity in British Columbia, Canada. [Comparative Study Research Support, Non-U.S. Gov't]. BMC cancer, 10, 154.
  130. Yen, T. W., Czypinski, L. K., Sparapani, R. A., Guo, C., Laud, P. W., Pezzin, L. E., et al. (2011). Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivors. [Research Support, N.I.H., Extramural]. Cancer, 117(2), 398-405.
  131. Yerushalmi, R., Woods, R., Kennecke, H., Speers, C., Knowling, M., & Gelmon, K. (2010). Patterns of relapse in breast cancer: changes over time. [Comparative Study]. Breast cancer research and treatment, 120(3), 753-759.


RECENT ARTICLES (I.E., PUBLISHED IN 2009, 2010, 2011, or 2012) ON PSYCHOLOGICAL ASPECTS OF BREAST CANCER (E.G., COGNITIVE CHANGES, ANXIETY, DEPRESSION, POST-TRAUMATIC GROWTH, STRESS MANAGEMENT, QUALITY OF LIFE, PTSD, PSYCHOSOCIAL & CLINICAL INTERVENTIONS):

  1. Agrawal, K., Onami, S., Mortimer, J. E., & Pal, S. K. (2010). Cognitive changes associated with endocrine therapy for breast cancer. Maturitas, 67(3), 209-214.
  2. Algoe, S. B., & Stanton, A. L. (2011). Gratitude when it is needed most: Social functions of gratitude in women with metastatic breast cancer. Emotion, No Pagination Specified.
  3. Anagnostopoulos, F., Slater, J., & Fitzsimmons, D. (2010). Intrusive thoughts and psychological adjustment to breast cancer: Exploring the moderating and mediating role of global meaning and emotional expressivity. Journal of Clinical Psychology in Medical Settings, 17(2), 137-149.
  4. Anderson, D. J., Yates, P., McCarthy, A., Lang, C. P., Hargraves, M., McCarthy, N., & Porter-Steele, J. (2011). Younger and older women's concerns about menopause after breast cancer. European Journal of Cancer Care,20(6), 785-794.
  5. Ando, N., Iwamitsu, Y., Kuranami, M., Okazaki, S., Nakatani, Y., Yamamoto, K., et al. (2011). Predictors of psychological distress after diagnosis in breast cancer patients and patients with benign breast problems. Psychosomatics: Journal of Consultation Liaison Psychiatry, 52(1), 56-64.
  6. Andreu, Y., Galdón, M. J., Durá, E., Martínez, P., Pérez, S., & Murgui, S. (2012). A longitudinal study of psychosocial distress in breast cancer: Prevalence and risk factors. Psychology & Health, 27(1), 72-87. 
  7. Ashing-Giwa, K. T., & Lim, J.-W. (2010). Exploring the association between functional strain and emotional well-being among a population-based sample of breast cancer survivors. Psycho-Oncology, 19(2), 150-159.
  8. Badr, H., & Milbury, K. (2011). Associations between depression, pain behaviors, and partner responses to pain in metastatic breast cancer. Pain, 152(11), 2596-2604.
  9. Beasley, J. M., Newcomb, P. A., Trentham-Dietz, A., Hampton, J. M., Ceballos, R. M., Titus-Ernstoff, L., et al. (2010). Social networks and survival after breast cancer diagnosis. Journal of Cancer Survivorship, 4(4), 372-380.
  10. Beatty, L., & Koczwara, B. (2010). An effectiveness study of a CBT group program for women with breast cancer. Clinical Psychologist, 14(2), 45-53.
  11. Belcher, A. J., Laurenceau, J.-P., Graber, E. C., Cohen, L. H., Dasch, K. B., & Siegel, S. D. (2011). Daily support in couples coping with early stage breast cancer: Maintaining intimacy during adversity. Health Psychology, 30(6), 665-673. 
  12. Bellizzi, K. M., Smith, A. W., Reeve, B. B., Alfano, C. M., Bernstein, L., Meeske, K., et al. (2010). Posttraumatic growth and health-related quality of life in a racially diverse cohort of breast cancer survivors. Journal of Health Psychology, 15(4), 615-626.
  13. Biglia, N., Moggio, G., Peano, E., Sgandurra, P., Ponzone, R., Nappi, R. E., et al. (2010). Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight. Journal of Sexual Medicine, 7(5), 1891-1900.
  14. Blacklock, R., Rhodes, R., Blanchard, C., & Gaul, C. (2010). Effects of exercise intensity and self-efficacy on state anxiety with breast cancer survivors. Oncology Nursing Forum, 37(2), 206-212.
  15. Bond, B. E., Connolly, A., & Asci, S. (2010). Coping with inflammatory breast cancer: Women's experiences. Journal of Psychosocial Oncology, 28(5), 539-559.
  16. Boot, J. S., Holcombe, C., & Salmon, P. (2010). Positive adjustment to breast cancer: Development of a disease-specific measure and comparison of women diagnosed from 2 weeks to 5 years. Psycho-Oncology, 19(11), 1187-1194.
  17. Brunet, J., McDonough, M. H., Hadd, V., Crocker, P. R. E., & Sabiston, C. M. (2010). The Posttraumatic Growth Inventory: An examination of the factor structure and invariance among breast cancer survivors. Psycho-Oncology, 19(8), 830-838.
  18. Calvio, L., Peugeot, M., Bruns, G. L., Todd, B. L., & Feuerstein, M. (2010). Measures of cognitive function and work in occupationally active breast cancer survivors. Journal of Occupational and Environmental Medicine, 52(2), 219-227.
  19. Canady, B. E., Naus, M. J., & Babcock, J. C. (2010). Physical and psychological abuse in breast cancer survivors and cancer-free women. Journal of Psychosocial Oncology, 28(4), 351-360.
  20. Capozzo, M. A., Martinis, E., Pellis, G., & Giraldi, T. (2010). An early structured psychoeducational intervention in patients with breast cancer: Results from a feasibility study. Cancer Nursing, 33(3), 228-234.
  21. Christie, K. M., Meyerowitz, B. E., & Maly, R. C. (2010). Depression and sexual adjustment following breast cancer in low-income Hispanic and non-Hispanic White women. Psycho-Oncology, 19(10), 1069-1077.
  22. Cimprich, B., Reuter-Lorenz, P., Nelson, J., Clark, P. M., Therrien, B., Normolle, D., et al. (2010). Prechemotherapy alterations in brain function in women with breast cancer. Journal of Clinical and Experimental Neuropsychology, 32(3), 324-331.
  23. Cohen, M., & Numa, M. (2011). Posttraumatic growth in breast cancer survivors: A comparison of volunteers and non-volunteers. Psycho-Oncology, 20(1), 69-76.
  24. Colagiuri, B., Christensen, S., Jensen, A. B., Price, M. A., Butow, P. N., & Zachariae, R. (2011). Prevalence and predictors of sleep difficulty in a national cohort of women with primary breast cancer three to four months postsurgery. Journal of Pain and Symptom Management, 42(5), 710-720.
  25. Cox, C. R., Reid-Arndt, S. A., Arndt, J., & Moser, R. P. (2012). Considering the unspoken: The role of death cognition in quality of life among women with and without breast cancer. Journal of Psychosocial Oncology, 30(1), 128-139. 
  26. Dahl, C. A. F., Reinertsen, K. V., Nesvold, I.-L., Fosså, S. D., & Dahl, A. A. (2010). A study of body image in long-term breast cancer survivors. Cancer, 116(15), 3549-3557.
  27. Dasch, K. B., Cohen, L. H., Belcher, A., Laurenceau, J.-P., Kendall, J., Siegel, S., et al. (2010). Affective differentiation in breast cancer patients. Journal of Behavioral Medicine, 33(6), 441-453.
  28. Davey, M. P., Kissil, K., Niño, A., & Tubbs, C. Y. (2010). "They paid no mind to my state of mind": African American breast cancer patients' experiences of cancer care delivery. Journal of Psychosocial Oncology, 28(6), 683-698.
  29. Demiralp, M., Oflaz, F., & Komurcu, S. (2010). Effects of relaxation training on sleep quality and fatigue in patients with breast cancer undergoing adjuvant chemotherapy. Journal of Clinical Nursing, 19(7-8), 1073-1083.
  30. den Heijer, M., Vanheusden, K., Seynaeve, C., Duivenvoorden, H. J., van Dooren, S., Bartels, K. C. M., et al. (2010). Distress in partners of high-risk women undergoing breast cancer surveillance. Journal of Men's Health, 7(4), 413-419.
  31. Deprez, S., Amant, F., Yigit, R., Porke, K., Verhoeven, J., Van den Stock, J., et al. (2011). Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Human Brain Mapping, 32(3), 480-493.
  32. Duijts, S. F. A., Faber, M. M., Oldenburg, H. S. A., van Beurden, M., & Aaronson, N. K. (2011). Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors—A meta-analysis. Psycho-Oncology, 20(2), 115-126.
  33. Dunn, L. B., Cooper, B. A., Neuhaus, J., West, C., Paul, S., Aouizerat, B., & Miaskowski, C. (2011). Identification of distinct depressive symptom trajectories in women following surgery for breast cancer. Health Psychology, 30(6), 683-692.
  34. Fisher, C. L. (2010). Coping with breast cancer across adulthood: Emotional support communication in the mother-daughter bond. Journal of Applied Communication Research, 38(4), 386-411.
  35. Gall, T. L., Charbonneau, C., & Florack, P. (2011). The relationship between religious/spiritual factors and perceived growth following a diagnosis of breast cancer. Psychology & Health, 26(3), 287-305.
  36. Garlick, M., Wall, K., Corwin, D., & Koopman, C. (2011). Psycho-spiritual integrative therapy for women with primary breast cancer. Journal of Clinical Psychology in Medical Settings, 18(1), 78-90.
  37. Garssen, B., Vos, P., de Jager Meezenbroek, E., de Klerk, C., & Visser, A. (2011). Analyzing differences between psychotherapy groups and social support groups for breast cancer patients: Development of an assessment method using video recordings. Patient Education and Counseling, 82(3), 377-383.
  38. Goldsmith, R. E., Jandorf, L., Valdimarsdottir, H., Amend, K. L., Stoudt, B. G., Rini, C., et al. (2010). Traumatic stress symptoms and breast cancer: The role of childhood abuse. Child Abuse & Neglect, 34(6), 465-470.
  39. Gorman, J. R., Roesch, S. C., Parker, B. A., Madlensky, L., Saquib, N., Newman, V. A., et al. (2010). Physical and mental health correlates of pregnancy following breast cancer. Psycho-Oncology, 19(5), 517-524.
  40. Gorman, J. R., Usita, P. M., Madlensky, L., & Pierce, J. P. (2011). Young breast cancer survivors: Their perspectives on treatment decisions and fertility concerns. Cancer Nursing, 34(1), 32-40.
  41. Grassi, L., Rossi, E., Cobianchi, M., Aguiari, L., Capozzo, M., Martinis, E., et al. (2010). Depression and serotonin transporter (5-HTTLPR) polymorphism in breast cancer patients. Journal of Affective Disorders, 124(3), 346-350.
  42. Gremore, T. M., Baucom, D. H., Porter, L. S., Kirby, J. S., Atkins, D. C., & Keefe, F. J. (2011). Stress buffering effects of daily spousal support on women's daily emotional and physical experiences in the context of breast cancer concerns. Health Psychology, 30(1), 20-30.
  43. Gullatte, M. M., Brawley, O., Kinney, A., Powe, B., & Mooney, K. (2010). Religiosity, spirituality, and cancer fatalism beliefs on delay in breast cancer diagnosis in African American women. Journal of Religion and Health, 49(1), 62-72.
  44. Hartl, K., Engel, J., Herschbach, P., Reinecker, H., Sommer, H., & Friese, K. (2010). Personality traits and psychosocial stress: Quality of life over 2 years following breast cancer diagnosis and psychological impact factors. Psycho-Oncology, 19(2), 160-169.
  45. Hartl, K., Schennach, R., Moller, M., Engel, J., Reinecker, H., Sommer, H., et al. (2010). Quality of life, anxiety, and oncological factors: A follow-up study of breast cancer patients. Psychosomatics: Journal of Consultation Liaison Psychiatry, 51(2), 112-123.
  46. Halkett, G. K. B., Kristjanson, L. J., Lobb, E., O'Driscoll, C., Taylor, M., & Spry, N. (2010). Meeting breast cancer patients' information needs during radiotherapy: What can we do to improve the information and support that is currently provided? European Journal of Cancer Care, 19(4), 538-547.
  47. Hasson-Ohayon, I., Goldzweig, G., Braun, M., & Galinsky, D. (2010). Women with advanced breast cancer and their spouses: Diversity of support and psychological distress. Psycho-Oncology, 19(11), 1195-1204.
  48. Hawkins, R. P., Pingree, S., Shaw, B., Serlin, R. C., Swoboda, C., Han, J.-Y., et al. (2010). Mediating processes of two communication interventions for breast cancer patients. Patient Education and Counseling, 81(Suppl 1), S48-S53.
  49. Helgeson, V. S. (2010). Corroboration of growth following breast cancer: Ten years later. Journal of Social and Clinical Psychology, 29(5), 546-574.
  50. Henry, E. A., Schlegel, R. J., Talley, A. E., Molix, L. A., & Bettencourt, B. A. (2010). The feasibility and effectiveness of expressive writing for rural and urban breast cancer survivors. Oncology Nursing Forum, 37(6), 749-757.
  51. Henselmans, I., Fleer, J., de Vries, J., Baas, P. C., Sanderman, R., & Ranchor, A. V. (2010). The adaptive effect of personal control when facing breast cancer: Cognitive and behavioural mediators. Psychology & Health, 25(9), 1023-1040.
  52. Henselmans, I., Helgeson, V. S., Seltman, H., de Vries, J., Sanderman, R., & Ranchor, A. V. (2010). Identification and prediction of distress trajectories in the first year after a breast cancer diagnosis. Health Psychology, 29(2), 160-168.
  53. Ho, R. T. H., Potash, J. S., Fu, W., Wong, K. P. L., & Chan, C. L. W. (2010). Changes in breast cancer patients after psychosocial intervention as indicated in drawings. Psycho-Oncology, 19(4), 353-360.
  54. Ho, S. M. Y., Chan, M. W. Y., Yau, T. K., & Yeung, R. M. W. (2011). Relationships between explanatory style, posttraumatic growth and posttraumatic stress disorder symptoms among Chinese breast cancer patients. Psychology & Health, 26(3), 269-285.
  55. Hong, Y., Wang, J.-P., Mei, Y.-L., Zhang, H.-W., & Tang, L.-L. (2010). [Effects of group psychological intervention on the quality of life in breast cancer patients.]. Chinese Mental Health Journal, 24(12), 903-907.
  56. Hopko, D. R., Armento, M. E. A., Robertson, S. M. C., Ryba, M. M., Carvalho, J. P., Colman, L. K., . . . Lejuez, C. W. (2011). Brief behavioral activation and problem-solving therapy for depressed breast cancer patients: Randomized trial. Journal of Consulting and Clinical Psychology, 79(6), 834-849. 
  57. Hopko, D. R., & Colman, L. K. (2010). The impact of cognitive interventions in treating depressed breast cancer patients. Journal of Cognitive Psychotherapy, 24(4), 314-328.
  58. Jabson, J. M., Donatelle, R. J., & Bowen, D. J. (2011). Relationship between sexual orientation and quality of life in female breast cancer survivors. Journal of Women's Health, 20(12), 1819-1824.
  59. Jensen, M. P., Gralow, J. R., Braden, A., Gertz, K. J., Fann, J. R., & Syrjala, K. L. (2012). Hypnosis for symptom management in women with breast cancer: A pilot study. International Journal of Clinical and Experimental Hypnosis,60(2), 135-159.
  60. Jones, J. M., Cheng, T., Jackman, M., Rodin, G., Walton, T., & Catton, P. (2010). Self-efficacy, perceived preparedness, and psychological distress in women completing primary treatment for breast cancer. Journal of Psychosocial Oncology, 28(3), 269-290.
  61. Jones, S. L., Hadjistavropoulos, H. D., & Sherry, S. B. (2012). Health anxiety in women with early-stage breast cancer: What is the relationship to social support? Canadian Journal of Behavioural Science/Revue canadienne des sciences du comportement, 44(2), 108-116.
  62. Kaiser, K., Rauscher, G. H., Jacobs, E. A., Strenski, T. A., Ferrans, C. E., & Warnecke, R. B. (2011). The import of trust in regular providers to trust in cancer physicians among White, African American, and Hispanic breast cancer patients. Journal of General Internal Medicine, 26(1), 51-57.
  63. Katapodi, M. C., Dodd, M. J., Facione, N. C., Humphreys, J. C., & Lee, K. A. (2010). Why some women have an optimistic or a pessimistic bias about their breast cancer risk: Experiences, heuristics, and knowledge of risk factors. Cancer Nursing, 33(1), 64-73.
  64. Keuroghlian, A. S., Butler, L. D., Neri, E., & Spiegel, D. (2010). Hypnotizability, posttraumatic stress, and depressive symptoms in metastatic breast cancer. International Journal of Clinical and Experimental Hypnosis, 58(1), 39-52.
  65. Kim, J., Han, J. Y., Shaw, B., McTavish, F., & Gustafson, D. (2010). The roles of social support and coping strategies in predicting breast cancer patients’ emotional well-being: Testing mediation and moderation models. Journal of Health Psychology, 15(4), 543-552.
  66. Kinsinger, S. W., Laurenceau, J.-P., Carver, C. S., & Antoni, M. H. (2011). Perceived partner support and psychosexual adjustment to breast cancer. Psychology & Health, 26(12), 1571-1588. 
  67. Kraemer, L. M., Stanton, A. L., Meyerowitz, B. E., Rowland, J. H., & Ganz, P. A. (2011). A longitudinal examination of couples' coping strategies as predictors of adjustment to breast cancer. Journal of Family Psychology, 25(6), 963-972.
  68. Krychman, M. L., & Katz, A. (2012). Breast cancer and sexuality: Multi-modal treatment options. Journal of Sexual Medicine, 9(1), 5-13.
  69. Kydd, L. A., Reid, S. A., & Adams, J. (2010). The Breast Surgery Gallery: An educational and counseling tool for people with breast cancer or having prophylactic breast surgery. Clinical Journal of Oncology Nursing, 14(5), 643-648.
  70. Lally, R. M., & Underhill, M. L. (2012). Transition to breast cancer survivorship: A longitudinal qualitative follow-up study of two-year survivors. Journal of Psychosocial Oncology, 30(1), 97-127.
  71. Lam, W. W. T., Bonanno, G. A., Mancini, A. D., Ho, S., Chan, M., Hung, W. K., et al. (2010). Trajectories of psychological distress among Chinese women diagnosed with breast cancer. Psycho-Oncology, 19(10), 1044-1051.
  72. Lam, W. W. T., Shing, Y. T., Bonanno, G. A., Mancini, A. D., & Fielding, R. (2012). Distress trajectories at the first year diagnosis of breast cancer in relation to 6 years survivorship. Psycho-Oncology, 21(1), 90-99. 
  73. Lejbak, L., Vrbancic, M., & Crossley, M. (2010). Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer. Journal of Clinical and Experimental Neuropsychology, 32(8), 836-846.
  74. Lelorain, S., Bonnaud-Antignac, A., & Florin, A. (2010). Long term posttraumatic growth after breast cancer: Prevalence, predictors and relationships with psychological health. Journal of Clinical Psychology in Medical Settings, 17(1), 14-22.
  75. Lengacher, C. A., Reich, R. R., Post-White, J., Moscoso, M., Shelton, M. M., Barta, M., & Budhrani, P. (2012). Mindfulness based stress reduction in post-treatment breast cancer patients: An examination of symptoms and symptom clusters. Journal of Behavioral Medicine, 35(1), 86-94. 
  76. Levy, R. (2011). Core themes in a support group for spouses of breast cancer patients. Social Work with Groups: A Journal of Community and Clinical Practice, 34(2), 141-157.
  77. Ligibel, J. A., Partridge, A., Giobbie-Hurder, A., Campbell, N., Shockro, L., Salinadri, T., et al. (2010). Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer. Journal of Women's Health, 19(8), 1553-1559.
  78. Lilliehorn, S., Hamberg, K., Kero, A., & Salander, P. r. (2010). 'Admission into a helping plan': A watershed between positive and negative experiences in breast cancer. Psycho-Oncology, 19(8), 806-813.
  79. Maners, A., & Champion, V. L. (2011). Coping and quality of life outcomes in younger breast cancer survivors.Western Journal of Nursing Research, 33(8), 1106-1107
  80. Marcus, A. C., Garrett, K. M., Cella, D., Wenzel, L., Brady, M. J., Fairclough, D., et al. (2010). Can telephone counseling post-treatment improve psychosocial outcomes among early stage breast cancer survivors? Psycho-Oncology, 19(9), 923-932.
  81. Matchim, Y., Armer, J. M., & Stewart, B. R. (2011). Effects of Mindfulness-Based Stress Reduction (MBSR) on health among breast cancer survivors. Western Journal of Nursing Research, 33(8), 996-1016. 
  82. McDonald, B. C., & Saykin, A. J. (2011). Neurocognitive dimensions of breast cancer and its treatment. Neuropsychopharmacology, 36(1), 355-356.
  83. McDowell, H., Kim, E., Shaw, B. R., Han, J. Y., & Gumieny, L. (2010). Predictors and effects of training on an online health education and support system for women with breast cancer. Journal of Computer-Mediated Communication, 15(3), 412-426.
  84. Montgomery, G. H., Schnur, J. B., Erblich, J., Diefenbach, M. A., & Bovbjerg, D. H. (2010). Presurgery psychological factors predict pain, nausea, and fatigue one week after breast cancer surgery. Journal of Pain and Symptom Management, 39(6), 1043-1052.
  85. Montgomery, M., & McCrone, S. H. (2010). Psychological distress associated with the diagnostic phase for suspected breast cancer: Systematic review. Journal of Advanced Nursing, 66(11), 2372-2390.
  86. Moore, T. A., Berger, A. M., & Dizona, P. (2011). Sleep aid use during and following breast cancer adjuvant chemotherapy. Psycho-Oncology, 20(3), 321-325.
  87. Moreira, H., & Canavarro, M. C. (2010). A longitudinal study about the body image and psychosocial adjustment of breast cancer patients during the course of the disease. European Journal of Oncology Nursing, 14(4), 263-270.
  88. Mosher, C. E., & DuHamel, K. N. (2012). An examination of distress, sleep, and fatigue in metastatic breast cancer patients. Psycho-Oncology, 21(1), 100-107.
  89. Mosher, C. E., DuHamel, K. N., Egert, J., & Smith, M. Y. (2010). Self-efficacy for coping with cancer in a multiethnic sample of breast cancer patients: Associations with barriers to pain management and distress. The Clinical Journal of Pain, 26(3), 227-234.
  90. Mosher, C. E., DuHamel, K. N., Lam, J., Dickler, M., Li, Y., Massie, M. J., & Norton, L. (2012). Randomised trial of expressive writing for distressed metastatic breast cancer patients. Psychology & Health, 27(1), 88-100. 
  91. Nakaya, N., Saito-Nakaya, K., Bidstrup, P. E., Dalton, S. O., Frederiksen, K., Steding-Jessen, M., et al. (2010). Increased risk of severe depression in male partners of women with breast cancer. Cancer, 116(23), 5527-5534.
  92. Namkoong, K., Shah, D. V., Han, J. Y., Kim, S. C., Yoo, W., Fan, D., et al. (2010). Expression and reception of treatment information in breast cancer support groups: How health self-efficacy moderates effects on emotional well-being. Patient Education and Counseling, 81(Suppl 1), S41-S47.
  93. Nash, M. R., & Tasso, A. (2010). The effectiveness of hypnosis in reducing pain and suffering among women with metastatic breast cancer and among women with temporomandibular disorder. International Journal of Clinical and Experimental Hypnosis, 58(4), 497-504.
  94. Oktay, J. S., Bellin, M. H., Scarvalone, S., Appling, S., & Helzlsouer, K. J. (2011). Managing the impact of posttreatment fatigue on the family: Breast cancer survivors share their experiences. Families, Systems, & Health, 29(2), 127-137.
  95. Otte, J. L., Carpenter, J. S., Russell, K. M., Bigatti, S., & Champion, V. L. (2010). Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivors. Journal of Pain and Symptom Management, 39(3), 535-547.
  96. Pascal, J. (2010). Space, place, and psychosocial well-being: Women's experience of breast cancer at an environmental retreat. Illness, Crisis, & Loss, 18(3), 201-216.
  97. Pieterse, A. H., Ausems, M. G. E. M., Spreeuwenberg, P., & van Dulmen, S. (2011). Longer-term influence of breast cancer genetic counseling on cognitions and distress: Smaller benefits for affected versus unaffected women. Patient Education and Counseling, 85(3), 425-431.
  98. Phillips, K. M., Antoni, M. H., Carver, C. S., Lechner, S. C., Penedo, F. J., McCullough, M. E., . . . Blomberg, B. B. (2011). Stress management skills and reductions in serum cortisol across the year after surgery for non-metastatic breast cancer. Cognitive Therapy and Research, 35(6), 595-600. 
  99. Pullens, M. J. J., De Vries, J., & Roukema, J. A. (2010). Subjective cognitive dysfunction in breast cancer patients: A systematic review. Psycho-Oncology, 19(11), 1127-1138.
  100. Quillin, J. M., Bodurtha, J. N., McClish, D., & Wilson, D. B. (2011). Genetic risk, perceived risk, and cancer worry in daughters of breast cancer patients. Journal of Genetic Counseling, 20(2), 157-164.
  101. Reid-Amdt, S. A., Hsieh, C., & Perry, M. C. (2010). Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer. Psycho-Oncology, 19(5), 535-544.
  102. Repass, M., & Matusitz, J. (2010). Problematic integration theory: Implications of supportive communication for breast cancer patients. Health Care for Women International, 31(5), 402-420.
  103. Rogers, L. Q., Vicari, S., & Courneya, K. S. (2010). Lessons learned in the trenches: Facilitating exercise adherence among breast cancer survivors in a group setting. Cancer Nursing, 33(6), E10-E17.
  104. Rosedale, M., & Fu, M. R. (2010). Confronting the unexpected: Temporal, situational, and attributive dimensions of distressing symptom experience for breast cancer survivors. Oncology Nursing Forum, 37(1), E28-E33.
  105. Rottmann, N., Dalton, S. O., Christensen, J., Frederiksen, K., & Johansen, C. (2010). Self-efficacy, adjustment style and well-being in breast cancer patients: A longitudinal study. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation, 19(6), 827-836.
  106. Salzer, M. S., Palmer, S. C., Kaplan, K., Brusilovskiy, E., Have, T. T., Hampshire, M., et al. (2010). A randomized, controlled study of internet peer-to-peer interactions among women newly diagnosed with breast cancer. Psycho-Oncology, 19(4), 441-446.
  107. Sammarco, A., & Konecny, L. M. (2010). Quality of life, social support, and uncertainty among Latina and Caucasian breast cancer survivors: A comparative study. Oncology Nursing Forum, 37(1), 93-99.
  108. Sawin, E. M. (2012). "The Body Gives Way, Things Happen”: Older women describe breast cancer with a non-supportive intimate partner. European Journal of Oncology Nursing, 16(1), 64-70.
  109. Schilder, C. M., Seynaeve, C., Linn, S. C., Boogerd, W., Gundy, C. M., Beex, L. V., et al. (2010). The impact of different definitions and reference groups on the prevalence of cognitive impairment: A study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy. Psycho-Oncology, 19(4), 415-422.
  110. Schlegel, R. J., Manning, M. A., Molix, L. A., Talley, A. E., & Bettencourt, B. A. (2012). Predictors of depressive symptoms among breast cancer patients during the first year post diagnosis. Psychology & Health, 27(3), 277-293. 
  111. Seok, J.-H., Kim, L. S., Hong, N., Hong, H. J., Kim, S.-J., Kang, H. J., et al. (2010). Psychological and neuroendocrinological characteristics associated with depressive symptoms in breast cancer patients at the initial cancer diagnosis. General Hospital Psychiatry, 32(5), 503-508.
  112. Sheridan, M. A., Sherman, M. L., Pierce, T., & Compas, B. E. (2010). Social support, social constraint, and affect in spouses of women with breast cancer: The role of cognitive processing. Journal of Social and Personal Relationships, 27(1), 5-22.
  113. Sherman, K. A., Heard, G., & Cavanagh, K. L. (2010). Psychological effects and mediators of a group multi-component program for breast cancer survivors. Journal of Behavioral Medicine, 33(5), 378-391.
  114. Snyder, K. A., & Pearse, W. (2010). Crisis, social support, and the family response: Exploring the narratives of young breast cancer survivors. Journal of Psychosocial Oncology, 28(4), 413-431.
  115. So, W. K. W., Marsh, G., Ling, W. M., Leung, F. Y., Lo, J. C. K., Yeung, M., et al. (2010). Anxiety, depression and quality of life among Chinese breast cancer patients during adjuvant therapy. European Journal of Oncology Nursing, 14(1), 17-22.
  116. Sohl, S. J., Schnur, J. B., Sucala, M., David, D., Winkel, G., & Montgomery, G. H. (2012). Distress and emotional well-being in breast cancer patients prior to radiotherapy: An expectancy-based model. Psychology & Health, 27(3), 347-361.
  117. Sperry, L. (2010). Breast cancer, depression, culture, and marital conflict. The Family Journal, 18(1), 62-65.
  118. Stang, I., & Mittelmark, M. B. (2010). Intervention to enhance empowerment in breast cancer self-help groups. Nursing Inquiry, 17(1), 47-57.
  119. Swainston, K., Campbell, C., van Wersch, A., & Durning, P. (2012). Treatment decision making in breast cancer: A longitudinal exploration of women's experiences. British Journal of Health Psychology, 17(1), 155-170. 
  120. Thornton, L. M., Andersen, B. L., & Blakely, W. P. (2010). The pain, depression, and fatigue symptom cluster in advanced breast cancer: Covariation with the hypothalamic–pituitary–adrenal axis and the sympathetic nervous system. Health Psychology, 29(3), 333-337.
  121. Tiedtke, C., de Rijk, A., de Casterlé, B. D., Christiaens, M.-R., & Donceel, P. (2010). Experiences and concerns about 'returning to work' for women breast cancer survivors: A literature review. Psycho-Oncology, 19(7), 677-683.
  122. Vahdaninia, M., Omidvari, S., & Montazeri, A. (2010). What do predict anxiety and depression in breast cancer patients? A follow-up study. Social Psychiatry and Psychiatric Epidemiology, 45(3), 355-361.
  123. Vilhauer, R. P., McClintock, M. K., & Matthews, A. K. (2010). Online support groups for women with metastatic breast cancer: A feasibility pilot study. Journal of Psychosocial Oncology, 28(5), 560-586.
  124. Vodermaier, A., Caspari, C., Wang, L., Koehm, J., Ditsch, N., & Untch, M. (2011). How and for whom are decision aids effective? Long-term psychological outcome of a randomized controlled trial in women with newly diagnosed breast cancer. Health Psychology, 30(1), 12-19.
  125. Walsh-Childers, K., Edwards, H., & Grobmyer, S. (2011). Covering women's greatest health fear: Breast cancer information in consumer magazines. Health Communication, 26(3), 209-220.
  126. Warren, M. (2010). Uncertainty, lack of control and emotional functioning in women with metastatic breast cancer: A review and secondary analysis of the literature using the critical appraisal technique. European Journal of Cancer Care, 19(5), 564-574.
  127. Wefel, J. S., Saleeba, A. K., Buzdar, A. U., & Meyers, C. A. (2010). Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer, 116(14), 3348-3356.
  128. Weinberger, T., Forrester, A., Markov, D., Chism, K., & Kunkel, E. J. S. (2010). Women at a dangerous intersection: Diagnosis and treatment of depression and related disorders in patients with breast cancer. Psychiatric Clinics of North America, 33(2), 409-422.
  129. Wu, S. M., & Andersen, B. L. (2010). Stress generation over the course of breast cancer survivorship. Journal of Behavioral Medicine, 33(3), 250-257.
  130. Yamada, T. H., Denburg, N. L., Beglinger, L. J., & Schultz, S. K. (2010). Neuropsychological outcomes of older breast cancer survivors: Cognitive features ten or more years after chemotherapy. The Journal of Neuropsychiatry and Clinical Neurosciences, 22(1), 48-54.
  131. Zimmermann, T., Scott, J. L., & Heinrichs, N. (2010). Individual and dyadic predictors of body image in women with breast cancer. Psycho-Oncology, 19(10), 1061-1068.

LINKS TO WEB SITES THAT MAY BE USEFUL IN FINDING INFORMATION, GUIDANCE, AND SUPPORT:

 

[Back to Top]